Peer Comparison
| Company | Market Price | MCAP(Cr) | P/B | P/E | EPS | ROE |
|---|---|---|---|---|---|---|
| IPCALAB | 884.25(-1.8%) | 22,795 | 3.8 | 46.4 | 11.8 | 8.9 |
| JBCHEPHARM | 1442.15(0.0%) | 22,255 | 8.9 | 49.8 | 22.8 | 18.5 |
| GLENMARK | 827.7(-2.7%) | 23,365 | 2.4 | 92.4 | 9.2 | 4.1 |
| PEL | 1046.65(0.0%) | 23,522 | 0.8 | 10.1 | 11.7 | 30.0 |
| AJANTPHARM | 1678(-2.6%) | 21,664 | 6.6 | 34.9 | 22.6 | 17.7 |
| LAURUSLABS | 390.7(0.0%) | 21,037 | 5.2 | 37.3 | 23.0 | 21.6 |
| GLAXO | 1550.1(-0.3%) | 26,324 | 14.1 | 42.3 | 16.5 | 5.5 |
| GLAND | 1694.85(-0.3%) | 27,901 | 3.4 | 37.4 | 14.0 | 10.3 |
| PFIZER | 3831.9(-0.1%) | 17,558 | 5.3 | 128.0 | 27.6 | 20.6 |
| SANOFI | 7148.35(0.6%) | 16,464 | 22.7 | 105.7 | 59.8 | 40.8 |
| NATCOPHARM | 859.95(1.4%) | 15,394 | 3.0 | 19.0 | 18.1 | 15.7 |
| APLLTD | 764.85(-0.9%) | 15,051 | 3.4 | 28.5 | 7.2 | 7.1 |
| SUVENPHAR | 532.65(-0.7%) | 13,629 | 7.3 | 32.0 | 44.5 | 37.8 |
| BIOCON | 265.35(-1.2%) | 32,062 | 1.8 | 76.4 | 16.1 | 18.0 |
| ASTRAZEN | 4517.8(0.0%) | 11,277 | 17.6 | 84.8 | 24.5 | 18.1 |
